Karyopharm Therapeutics Inc.
KPTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,127 | -$37,252 | -$23,462 | -$30,780 |
| Dep. & Amort. | $0 | -$42 | $78 | $2,438 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,784 | $3,560 | $3,864 |
| Change in WC | $0 | $10,050 | -$1,525 | $10,084 |
| Other Non-Cash | $33,127 | $4,763 | -$17,635 | -$11,416 |
| Operating Cash Flow | $0 | -$18,697 | -$38,984 | -$25,810 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $53 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $18,285 | $15,288 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $14,744 |
| Investing Cash Flow | $0 | $18,285 | $15,288 | $14,797 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $356 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $680 |
| Financing Cash Flow | $0 | $356 | $0 | $680 |
| Forex Effect | $0 | $8 | $5 | -$20 |
| Net Chg. in Cash | -$39,075 | -$48 | -$23,691 | -$10,353 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,075 | $39,123 | $62,814 | $73,167 |
| End Cash | $0 | $39,075 | $39,123 | $62,814 |
| Free Cash Flow | $0 | -$18,697 | -$38,984 | -$25,757 |